-
1
-
-
84929481481
-
Pembrolizumab versus ipilimumab in advanced melanoma
-
Robert C, Schachter J, Long GV et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl JMed 2015;372:2521-2532.
-
(2015)
N Engl JMed
, vol.372
, pp. 2521-2532
-
-
Robert, C.1
Schachter, J.2
Long, G.V.3
-
2
-
-
84937759727
-
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
-
Mahoney KM, Freeman GJ, McDermott DF. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma. Clin Ther 2015;37:764-782.
-
(2015)
Clin Ther
, vol.37
, pp. 764-782
-
-
Mahoney, K.M.1
Freeman, G.J.2
McDermott, D.F.3
-
3
-
-
84872339660
-
The price of tumor control: An analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
-
Voskens CJ, Goldinger SM, Loquai C et al. The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network. PLoS One 2013;8:e53745.
-
(2013)
PLoS One
, vol.8
-
-
Voskens, C.J.1
Goldinger, S.M.2
Loquai, C.3
-
4
-
-
84922738416
-
Peripheral neuropathy associated with ipilimumab: A report of 2 cases
-
Thaipisuttikul I, Chapman P, Avila EK. Peripheral neuropathy associated with ipilimumab: A report of 2 cases. J Immunother 2015;38:77-79.
-
(2015)
J Immunother
, vol.38
, pp. 77-79
-
-
Thaipisuttikul, I.1
Chapman, P.2
Avila, E.K.3
-
5
-
-
84883053806
-
Multifocal radiculoneuropathy during ipilimumab treatment of melanoma
-
Manousakis G, Koch J, Sommerville RB et al. Multifocal radiculoneuropathy during ipilimumab treatment of melanoma. Muscle Nerve 2013;48:440-444.
-
(2013)
Muscle Nerve
, vol.48
, pp. 440-444
-
-
Manousakis, G.1
Koch, J.2
Sommerville, R.B.3
-
6
-
-
84896934432
-
Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma
-
Liao B, Shroff S, Kamiya-Matsuoka C et al. Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma. Neuro Oncol 2014;16:589-593.
-
(2014)
Neuro Oncol
, vol.16
, pp. 589-593
-
-
Liao, B.1
Shroff, S.2
Kamiya-Matsuoka, C.3
-
7
-
-
79953300714
-
Anti-CTLA-4 antibodyinduced Guillain-Barré syndrome in a melanoma patient
-
Wilgenhof S, Neyns B. Anti-CTLA-4 antibodyinduced Guillain-Barré syndrome in a melanoma patient. Ann Oncol 2011;22:991-3.
-
(2011)
Ann Oncol
, vol.22
, pp. 991-993
-
-
Wilgenhof, S.1
Neyns, B.2
-
8
-
-
84875531958
-
Severe meningo-radiculo-neuritis associated with ipilimumab
-
Bompaire F, Mateus C, Taillia H et al. Severe meningo-radiculo-neuritis associated with ipilimumab. Invest New Drugs 2012;30:2407-2410.
-
(2012)
Invest New Drugs
, vol.30
, pp. 2407-2410
-
-
Bompaire, F.1
Mateus, C.2
Taillia, H.3
-
9
-
-
84952863785
-
Meningoencephalitis Following Ipilimumab Administration in Metastatic Melanoma
-
Stein MK, Summers BB, Wong CA et al. Meningoencephalitis Following Ipilimumab Administration in Metastatic Melanoma. Am J Med Sci 2015;350:512-513.
-
(2015)
Am J Med Sci
, vol.350
, pp. 512-513
-
-
Stein, M.K.1
Summers, B.B.2
Wong, C.A.3
-
10
-
-
84964294839
-
Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature
-
Abdallah A-O, Herlopian A, Ravilla R et al. Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature. J Oncol Pharm Pract 2016; 22:537-542.
-
(2016)
J Oncol Pharm Pract
, vol.22
, pp. 537-542
-
-
Abdallah, A.-O.1
Herlopian, A.2
Ravilla, R.3
-
12
-
-
84964389238
-
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
-
Zimmer L, Goldinger SM, Hofmann L et al. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer 2016;60:210-225.
-
(2016)
Eur J Cancer
, vol.60
, pp. 210-225
-
-
Zimmer, L.1
Goldinger, S.M.2
Hofmann, L.3
-
13
-
-
84962409041
-
Limbic encephalitis following immunotherapy against metastatic malignant melanoma
-
pii:bcr 2016215012
-
Salam S, Lavin T, Turan A. Limbic encephalitis following immunotherapy against metastatic malignant melanoma. BMJ Case Rep 2016;pii:bcr 2016215012.
-
(2016)
BMJ Case Rep
-
-
Salam, S.1
Lavin, T.2
Turan, A.3
-
14
-
-
84962439197
-
Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma
-
Maurice C, Schneider R, Kiehl T-R et al. Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma. Cancer Immunol Res 2015;3:1299-1302.
-
(2015)
Cancer Immunol Res
, vol.3
, pp. 1299-1302
-
-
Maurice, C.1
Schneider, R.2
Kiehl, T.-R.3
-
15
-
-
84906794549
-
Lambrolizumab induced central nervous system (CNS) toxicity
-
Mandel JJ, Olar A, Aldape KD et al. Lambrolizumab induced central nervous system (CNS) toxicity. J Neurol Sci 2014;344:229-231.
-
(2014)
J Neurol Sci
, vol.344
, pp. 229-231
-
-
Mandel, J.J.1
Olar, A.2
Aldape, K.D.3
-
16
-
-
84981271733
-
Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer
-
Williams TJ, Benavides DR, Patrice KA et al. Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer. JAMA Neurol 2016; 73:928-933.
-
(2016)
JAMA Neurol
, vol.73
, pp. 928-933
-
-
Williams, T.J.1
Benavides, D.R.2
Patrice, K.A.3
-
18
-
-
0142009530
-
Paraneoplastic syndromes involving the nervous system
-
Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003;349:1543-1554.
-
(2003)
N Engl J Med
, vol.349
, pp. 1543-1554
-
-
Darnell, R.B.1
Posner, J.B.2
-
19
-
-
0035142625
-
Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody
-
Barnett M, Prosser J, Sutton I et al. Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody. J Neurol Neurosurg Psychiatry 2001; 70:222-225.
-
(2001)
J Neurol Neurosurg Psychiatry
, vol.70
, pp. 222-225
-
-
Barnett, M.1
Prosser, J.2
Sutton, I.3
-
21
-
-
85020943756
-
Merck
-
Available at, Accessed March 29
-
Merck. Prescribing Information for Keytruda 2014-2016. Available at https://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf. Accessed March 29, 2017.
-
(2017)
Prescribing Information for Keytruda 2014-2016
-
-
-
22
-
-
84884349954
-
Brainstem encephalitis: Etiologies, treatment, and predictors of outcome
-
Tan IL, Mowry EM, Steele SU et al. Brainstem encephalitis: Etiologies, treatment, and predictors of outcome. J Neurol 2013;260:2312-2319.
-
(2013)
J Neurol
, vol.260
, pp. 2312-2319
-
-
Tan, I.L.1
Mowry, E.M.2
Steele, S.U.3
|